menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Personalizing Relapsed/Refractory CLL Care: Key Factors to Consider

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Related
Comments
  • Sponsored by

  • Overview

    From previous treatment regimens to comorbidities, there are a lot of disease- and patient-specific factors to keep in mind when creating personalized treatment plans for patients with relapsed/refractory chronic lymphocytic leukemia (CLL). But to ensure optimal outcomes, it’s just as important to consider the patient’s unique preferences and treatment goals as well. That’s why Dr. Charles Turck speaks with Dr. Lindsey Roeker about these key factors and how we can balance them to create personalized CLL treatment plans. Dr. Roeker is a hematologist and medical oncologist at the Memorial Sloan Kettering Cancer Center in New York City.

Facebook Comments

Recommended
Details
Presenters
Related
Comments
  • Sponsored by

  • Overview

    From previous treatment regimens to comorbidities, there are a lot of disease- and patient-specific factors to keep in mind when creating personalized treatment plans for patients with relapsed/refractory chronic lymphocytic leukemia (CLL). But to ensure optimal outcomes, it’s just as important to consider the patient’s unique preferences and treatment goals as well. That’s why Dr. Charles Turck speaks with Dr. Lindsey Roeker about these key factors and how we can balance them to create personalized CLL treatment plans. Dr. Roeker is a hematologist and medical oncologist at the Memorial Sloan Kettering Cancer Center in New York City.

Facebook Comments

Schedule28 May 2024